glp 1 receptor agonists contraindications for Using information from the NPF Medical Board's publication in JAMA Dermatology contraindications for glp-1 Consensus Recommendations

(Normal BMI is between 18.5 and 24.9.) Obesity: A person has a BMI of 30.0 or greater

The study showed a 20% risk reduction of the primary outcome in the GLP-1 RA arm (HR 0.80

The chemistry review conducted by CDER for the NDA of liraglutide by Novo Nordisk A/S also mentions a hybrid manufacturing process

Alongside liraglutide, semaglutide has been shown to effectively improve motor impairments, rescue tyrosine hydroxylase (TH) levels, reduce -synuclein accumulation, chronic inflammation response in the brain and lipid peroxidation, inhibit mitochondrial mitophagy signaling and protect dopaminergic neurons in the substantia nigra and striatum in MPTP mouse models of PD [81]

This is a tool in their toolbox

Zhong J, Gong Q, Goud A, Srinivasamaharaj S, Rajagopalan S